Clinical trials
Blindness clinical trials
Below are recruiting blindness clinical trials, each written for real people, not researchers. We’re tracking 212 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06631287RecruitingPhase 3
Testing baricitinib for persistent long COVID symptoms
This trial tests whether the anti-inflammatory drug baricitinib can improve persistent long COVID symptoms like brain fog, fatigue, and shortness of breath. You may qualify if you had COVID-19 at least 6 months ago and still have bothersome symptoms that affect your daily life.
Tucson, ArizonaAges 18 years+ - NCT06600438Recruiting
Slow walking study for loss of smell
This study tests if a slow walking program can help prevent Parkinson's disease in people with a reduced sense of smell. You will be randomly assigned to a walking group or a control group and followed for 18 months.
LondonAges 40–100 - NCT06599099Recruiting
Deep brain stimulation for depression that hasn't responded to other treatments
This trial tests if deep brain stimulation (a surgical implant that sends gentle electrical pulses to a specific area of the brain) can help people with bipolar I disorder who are currently in a severe depressive episode and have not found relief from multiple treatments.
Boston, MassachusettsAges 22–64 - NCT06568627RecruitingPhase 3
Testing a gel for cleaning leg ulcers
This study tests a new gel that helps remove dead tissue from venous leg ulcers. Venous leg ulcers are open sores on the leg that happen when veins don't work well. The gel is applied to the ulcer to clean it and help it heal. You may be able to join if you are an adult with a venous leg ulcer that is not too large and has been there for a few weeks.
Phoenix, ArizonaAges 18 years+ - NCT06578117Enrolling by invitation
Visual training for stroke-related vision loss
This study tests whether a computer-based visual training program can help people who have lost vision after a stroke to their brain's visual center. You must have been in a prior study with the same team.
Rochester, New YorkAges 21–75 - NCT06535867Recruiting
Comparing phone-based vs. in-person mouth cancer screening in rural India
This study compares two ways to find early signs of mouth cancer or conditions that could lead to cancer. One method uses a simple phone-based health check, and the other uses standard in-person screening. People in rural areas of Varanasi who are at risk—such as those who use tobacco or have mouth sores—may be able to join.
New York, New YorkAges 18 years+ - NCT05290285Recruiting
Amino acids for anorexia nervosa, compared with placebo
This study tests whether taking certain amino acids can help people with anorexia nervosa. Participants are randomly assigned to amino acids or a placebo (a look-alike with no active ingredient) to see which works better.
Garda, ItalyAges 16–50 - NCT06488625RecruitingPhase 2/Phase 3
Nicotinamide for mild to moderate ulcerative colitis
This trial tests whether a special oral form of nicotinamide (a type of vitamin B3) can help control mild to moderate ulcerative colitis. The pill is designed to release the medication in the lower part of your gut, where UC often affects. Participation involves taking the study drug and having regular checkups to see how your symptoms and inflammation respond.
Kiel, Schleswig-HolsteinAges 18–80 - NCT06475521Enrolling by invitation
Study of a new infant formula for healthy babies
This study tests a new infant formula to see how healthy babies grow and develop. If your baby is healthy, full-term, and formula-fed, they may be able to join.
DupnitsaAges birth–2 weeks - NCT06455449RecruitingPhase 3
Injectable anifrolumab for polymyositis or dermatomyositis
This study tests a new injectable medicine (anifrolumab) added to your usual treatments for polymyositis or dermatomyositis. It may help reduce disease activity if you have moderate to severe symptoms and are already on stable therapy.
Phoenix, ArizonaAges 18–75 - NCT06446882Recruiting
HER2DX test to guide treatment for early HER2+ breast cancer
This trial tests whether a new test (HER2DX) can help doctors choose the best treatment combination for HER2-positive breast cancer before surgery. It's for people whose cancer hasn't spread and who haven't started therapy yet.
GrazAges 18 years+ - NCT06347770RecruitingPhase 1
Oral Gan Shuangbi for recovery after C-section
This trial tests an oral herbal medicine (Gan Shuangbi) to see if it helps your intestines work normally again after a C-section. It may speed up recovery after delivery.
Guangzhou, GuangdongAges 18–45 - NCT06328712RecruitingPhase 1/Phase 2
Cell therapy for Charcot-Marie-Tooth type 1A (CMT1A)
This trial tests a new cell therapy called EN001 for people with CMT1A. It aims to see if the treatment is safe and can help with nerve function and muscle weakness.
GyeongjuAges 19 years+ - NCT04121468RecruitingPhase 1/Phase 2
Metformin trial for vision nerve recovery in young people with MS
This study tests whether metformin can help “reset” damaged nerve cells in the brain and improve vision-related nerve problems in children and young adults with multiple sclerosis. Participants are assigned to metformin or a comparison treatment in a blinded (not everyone knows which) study.
Toronto, OntarioAges 10–25 - NCT06232876Recruiting
Continuous vs intermittent monitoring after surgery
This study compares two ways of monitoring patients after major surgery: continuous monitoring with a non‑invasive device versus the usual periodic checks. It may help find out which method is better at keeping you safe during recovery.
Houston, TexasAges 18 years+ - NCT06164613RecruitingPhase 2
Cinnamon for Inducing Labor in First-Time Teen Pregnancies
This study tests whether cinnamon capsules can help start labor in first-time pregnant teens who are full-term. It compares cinnamon to a placebo (fake pill) to see if it is safe and effective for inducing labor.
Tegucigalpa, Francisco Morazán DepartmentAges 14–45 - NCT06118840Recruiting
AI tool for spotting brain aneurysms on CT scans
This trial tests if an AI model can help doctors detect brain aneurysms more accurately on head CT angiograms (CTA). It may lead to earlier treatment and better outcomes.
Hefei, AnhuiAges 18 years+ - NCT06136585RecruitingPhase 3
Comparing two drugs to reverse muscle relaxants after ERCP
This trial compares two medications given to reverse the effects of muscle relaxants after an outpatient ERCP (a scope procedure). The goal is to see which drug works better and faster, which could help you wake up more comfortably.
Cleveland, OhioAges 18 years+ - NCT06128447RecruitingPhase 3
New chewable drug for hookworm, roundworm and whipworm
This trial tests a new chewable tablet (ZP5-9676) to treat common intestinal worm infections. It compares the new drug to a placebo (fake pill) to see if it's safe and effective.
AmericaninhaAges 6 months–59 years - NCT06117332Enrolling by invitation
AI-Enhanced Vision for People with Visual Implants
This study tests a new AI system designed to improve what people with visual prostheses 'see.' If you have an implanted device like the Argus II or Orion, you may be able to help by coming to the lab for several days of vision testing.
Santa Barbara, CaliforniaAges 18 years+ - NCT06127602Recruiting
Electrical stimulation plus walking for stroke recovery
This study tests whether adding a type of electrical stimulation to leg muscles during walking can improve walking ability for people who are at least 6 months past a stroke. If you have weakness on one side and can walk on a treadmill with some help, you may be able to join.
Chicago, IllinoisAges 18–90 - NCT06066801Recruiting
Bedside bone biopsy for diabetic foot infection
This trial is testing a new way to take a small sample of infected bone from the foot of people with diabetes. It aims to see if a bedside biopsy is safe and accurate for diagnosing bone infection, so you may avoid more invasive procedures.
ParisAges 18 years+ - NCT05641844Recruiting
Minimally invasive treatment for anal fistulas with a seton
This trial tests whether RD2 Ver.02 is safe and works better than a comparison treatment for treating anal fistulas using a less invasive approach. It may help people who have a seton in place and want to avoid major surgery like flap repair or LIFT.
Los Angeles, CaliforniaAges 18 years+ - NCT06032923RecruitingPhase 1/Phase 2
Does vitamin B3 boost help lupus symptoms?
This study tests whether a form of vitamin B3, called nicotinamide riboside, can improve immune function and reduce inflammation in women with mild to moderate lupus. It may help understand if boosting NAD+ levels offers a new way to manage the disease.
Bethesda, MarylandAges 18–120
Hear when a new Blindness trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for blindness?
- Yes. Clin2 currently lists 212 recruiting blindness studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a blindness trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a blindness trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.